Development Phases

Helping you efficiently transition from First Time in Human to Proof of Concept

Charité Research Organisation focuses on supporting your early clinical development needs. Our aim is to help you transition your product from First Time in Human to Proof of Concept as efficiently and quickly as possible. The labels applied vary a little from company to company, but broadly speaking this means we are undertaking the first studies in humans, ‘typical’ Phase I type studies and ‘classical’ Phase IIa or even full Phase II studies. We are able to bring patients into the very first studies, in addition to healthy volunteers.

First Time in Human

Charité Research Organisation is a specialist in the conduct of First Time in Human studies. We undertake ‘classical’ SAD design studies in healthy volunteers, through to adaptive design trials encompassing SAD, MAD and more, in a combination of healthy volunteers and patients. You want to run a single-centre study in n=92 RA patients, combining SAD and MAD with imaging and laboratory biomarkers? We have it covered.

Company

Scientific Expertise

Operational Excellence

Recruitment

Value

Helping you efficiently transition from First Time in Human to Proof of Concept

First Time in Human